Larson Financial Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,102
Closed -$36.9K 2919
2024
Q3
$36.9K Hold
7,102
﹤0.01% 987
2024
Q2
$18.3K Buy
+7,102
New +$18.3K ﹤0.01% 1079